Low dose combination antihypertensive therapy. Additional efficacy without additional adverse effects?
| Autor: | Angus M. MacConnachie, Derek Maclean |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Drug
medicine.medical_specialty Low dosage media_common.quotation_subject Sodium Chloride Symporter Inhibitors Pharmacology toxicology Adrenergic beta-Antagonists Angiotensin-Converting Enzyme Inhibitors Pharmacology Toxicology Benzothiadiazines Pharmacotherapy medicine Humans Pharmacology (medical) Intensive care medicine Adverse effect Diuretics Adrenergic alpha-Antagonists media_common business.industry Low dose Limiting Calcium Channel Blockers Hypertension Drug Therapy Combination business |
| Zdroj: | Drug safety. 12(2) |
| ISSN: | 0114-5916 |
| Popis: | The careful selection of first-line antihypertensive therapy using a variety of drug combinations might enable more precise control of hypertension at low dosage and in the absence of many dose-related and often limiting adverse effects. Further support for such a strategy may be forthcoming in the aftermath of the HOT study if the benefits of strict BP control on outcome in terms of survival and end-organ damage are eventually demonstrated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink